Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Current approaches to treatment for HIV-1 infection
William G. Powderly
Division of Infectious Diseases
Institute of Clinical and Translational Sciences (ICTS)
COVID-19 Researchers
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Department of Medicine
Institute for Public Health
Research output
:
Contribution to journal
›
Article
›
peer-review
29
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current approaches to treatment for HIV-1 infection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Advanced Disease
50%
Antiretroviral
50%
Antiretroviral Regimens
50%
Antiviral Resistance
50%
Best Time
50%
CD4+
50%
Clinical Endpoints
50%
Clinical Practice
50%
Cross-resistance
50%
Current Therapies
50%
Current Treatment
50%
Disease Survival
50%
Drug Interactions
50%
Evade
50%
Existing Drugs
50%
Four Factors
50%
HIV Disease
50%
HIV Infection
100%
HIV Viral Load
50%
HIV-1 Infection
100%
Improved Survival
50%
Long-term Toxicity
50%
Lymphoid Tissue
50%
Memory T Cells
50%
MRNA Level
50%
New Therapies
50%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
100%
Nucleoside Analogues
50%
Prior Treatment
50%
Protease
50%
Protease Inhibitors
50%
Resistant Virus
50%
Response to Therapy
50%
Therapy Goals
50%
Viral Burden
100%
Viral Load Monitoring
50%
Viral Replication
50%
Viral Reservoir
50%
Virological Response
50%
Virus
50%
Medicine and Dentistry
Clinical Endpoint
50%
Cross Resistance
50%
Disease
100%
Drug Interaction
50%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1 Infection
100%
Human Immunodeficiency Virus Infection
100%
Lymphatic Tissue
50%
Memory T Cell
50%
Nonnucleoside Reverse Transcriptase Inhibitor
100%
Nucleoside Analogue
50%
Proteinase
50%
Proteinase Inhibitor
50%
Viral Load Testing
50%
Virus Replication
50%
Virus Resistance
50%
Pharmacology, Toxicology and Pharmaceutical Science
Cross-Resistance
50%
Disease
100%
Drug-Drug Interaction
50%
HIV
100%
Human Immunodeficiency Virus 1 Infection
100%
Human Immunodeficiency Virus Infection
100%
Nonnucleoside Reverse Transcriptase Inhibitor
100%
Nucleoside Analog
50%
Proteinase
50%
Proteinase Inhibitor
50%
Virus Resistance
50%
Immunology and Microbiology
Blood Plasma
100%
CD4 Lymphocyte Count
33%
Cross-Resistance
33%
Drug-Drug Interaction
33%
Human Immunodeficiency Virus
33%
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus Infection
66%
Lymphoid Tissue
33%
Memory T Cell
33%
Reverse Transcriptase
66%
Viral Load
100%
Viral Replication
33%
Virus Resistance
33%